September 21, 2021
Open to all ISPOR Members and Non-members
Presented by:
- David Thompson, PhD
- Joakim Ramsberg, PhD
September 21, 2021
11:00AM EDT | 4:00PM BST | 5:00PM CEST
Click here for time zone conversion
Since first being described more than 50 years ago, the pragmatic clinical trial (PCT) has been considered the most scientifically rigorous of all real-world research designs. Yet, despite its promise, the PCT design has been relatively underutilized in comparison to other approaches for real-world evidence (RWE) generation. More recently, a variety of organizations have focused attention on the potential to embed clinical trials in real-world practice settings as a means of involving practicing physicians, recruiting real-world patients, and leveraging existing EHR systems for data capture. Is this approach better suited to RWE generation? Should we be talking “embedded” rather than “pragmatic” for real-world clinical trials? In this webinar, experts will explore embedded clinical trials and their potential for effectively generating real world evidence, and review case studies illustrating best practice for these trials in action.
Learning Objectives:
- Learn the defining characteristics of embedded clinical trials.
- Understand the similarities and differences between embedded and pragmatic trials.
- Identify if and when embedding clinical trials in real-world practice provides a more practical way of improving generalizability.
Register Now
Sponsored by: Syneos Health
Presenters:
David Thompson, PhD, Senior Vice President, Real World and Late Phase, Syneos Health, Boston, MA, USA
Joakim Ramsberg, PhD, Project Director and Chief Scientific Officer, Agency for Health and Care Services Analysis, Stockholm, Sweden
Reservations are on a first-come, first-served basis.